<?xml version="1.0" encoding="UTF-8"?>
<p id="par0065">According to another report [
 <xref rid="bib0205" ref-type="bibr">41</xref>], 108 adults have received a low, middle, or high dose of the vaccine, given as an intramuscular injection. All those adults were not affected by SARS-CoV-2, and their age was in between 18 and 90 years. Their mean age was 36.3, and 51% of them were male and observed for 28 days. Live virus or pseudovirus neutralization assays can detect neutralizing antibodies, in addition to binding antibodies measured by ELISA at approximately 14 days.
</p>
